Intron Biotechnology Inc. | Mutual Funds
Mutual Funds that own Intron Biotechnology Inc.
iShares Core MSCI Emerging Markets ETF
158,496
1.05%
0
0.01%
09/05/2018
Vanguard Total International Stock Index Fund
154,412
1.03%
0
0%
07/31/2018
122,722
0.82%
0
1.12%
09/06/2018
Manulife Global Fund - Asian Small Cap Equity Fund
70,000
0.47%
70,000
0.86%
12/31/2017
Vanguard Developed Markets Index Fund
65,002
0.43%
0
0%
07/31/2018
Pacific Horizon Investment Trust Plc
41,921
0.28%
0
0.57%
10/31/2017
Vanguard FTSE All World (ex-US) Small Cap
27,463
0.18%
0
0.01%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
23,858
0.16%
0
0.01%
09/05/2018
Mirae Asset TIGER Health Care ETF
23,808
0.16%
6,469
0.56%
04/30/2018
Government Pension Fund - Global (The)
20,485
0.14%
-99,100
0%
12/31/2017
| Address |
Unit 701-704, Joong-Ang Induspia
Seongnam-si GY 13202
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.intron.co.kr |
| Updated |
09/14/2018 |
| iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea. |
